FDA Label for Aromalief Soothing Pain Relief Cream Spearmint
View Indications, Usage & Precautions
Aromalief Soothing Pain Relief Cream Spearmint Product Label
The following document was submitted to the FDA by the labeler of this product Marketites Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Active Ingredients
Menthol 1.0% w/w
Otc - Purpose
Topical Analgesic
Indications & Usage
Use For temporary relief of pain
Warnings
Warnings
For external use only. Avoid contact with eyes.
Otc - Ask Doctor
Stop use and ask a doctor if condition worsens, symptoms persist for more than 7 days, or new symptoms occur.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children, if swallowed, get medical help or contact a Poison Control Center right away. If pregnant or breastfeeding, ask a health professional.
Directions
Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: consult a doctor.
Ohter Information
Store in a cool dry place between 68° and 77°F and relative humidity not exceeding 65%.
Do not use if seal is broken, torn or missing.
Inactive Ingredients
Aloe Barbadensis Leaf Extract, Water, Stearyl Alcohol, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Isopropyl Myristate, Glyceryl Stearate, Menthyl Lactate, Glycerin, PEG 100 Stearate, Cannabis Sativa Seed Oil, Ulva lactuca Linnaeus, Fucaceae Fucus Vesiculosus, Sodium Hyaluronate, Spearmint (Mentha Viridis), Maltodextrin, Glucosamine Sulfate, Dimethyl Sulfone (MSM), L-Arginine, Glycol Stearate, Phenoxyethanol, Caprylyl Glycol
Questions
Distributed by Marketites LLC
Coral Gables, FL 33134
Made in the USA
Questions? [email protected]
Package Label.Principal Display Panel
* Please review the disclaimer below.